Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Avedro’s Long Wait for FDA Approval is Over

    Avedro’s Long Wait for FDA Approval is Over

    FromOIS Podcast | Ophthalmology's leading Podcast

    Start listeningView podcast show

    Avedro’s Long Wait for FDA Approval is Over

    FromOIS Podcast | Ophthalmology's leading Podcast

    ratings:
    Length:
    13 minutes
    Released:
    Apr 20, 2016
    Format:
    Podcast episode

    Description

    The FDA approved Avedro’s New Drug Application for its riboflavin ophthalmic solution/KXL System (corneal cross-linking for the treatment of keratoconus and corneal ectasia following refractive surgery). OIS Co-chair Gil Kliman, an investor in Avedro, lays out the company’s next plans.
    Released:
    Apr 20, 2016
    Format:
    Podcast episode

    Titles in the series (100)

    Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.